30th June 2022, Seventh ParadigMS Symposium
Professor Giancarlo Comi gave a keynote on MS Care Unit during the Seventh Belgian ParadigMS Symposium.
This video interview with Prof Giancarlo Comi is based on this slide deck and brings out the key points. Consult here the video interview.
ABSTRACT
Treatment of multiple sclerosis (MS) has become increasingly multifaceted and comprises not only a variety of disease-modifying drugs with different mechanism of action but also a wide range of symptomatic therapies. Today, it is not possible for the family physician or even many general neurologists to master the current treatment algorithm, and this calls for the establishment of multidisciplinary MS Care Units. Although the main objective for establishment of MS Care Units will be to offer the single MS patient seamless and correct management of the disease to increase patient satisfaction and quality of life, it may even be cost-effective for the society by maintaining the working ability and reducing the costs of home help and custodial care by keeping people with MS resourceful.
QUESTIONS ASKED IN THE INTERVIEW
- What are the main challenges when treating patients with MS?
- What is the importance of establishing multidisciplinary MS Care Units?
- What are the main reasons why MS Care Units are not being implemented? How can we overcome these hurdles?
- When a hospital would like to set-up an MS Care Unit, what are the first steps to take?
BIOGRAPHY
GIANCARLO COMI
Institute of Experimental Neurology at Vita-Salute San Raffaele University, Milan, Italy
Giancarlo Comi is Professor of Neurology, Chairman of the Department of Neurology, and Director of the Institute of Experimental Neurology at Vita-Salute San Raffaele University, Milan, Italy. He is also President of the European Charcot Foundation (ECF), a member of the Board of Administration of the Italian Multiple Sclerosis Foundation and of the Scientific Committee of Associazione Italiana Sclerosi Multipla, Co-Chair of the Scientific Steering Committee of the Progressive MS Alliance, and a fellow of the European Academy of Neurology (EAN). He has served as a past president of the European Neurology Society, the Italian Society of Clinical Neurophysiology, and the Italian Society of Neurology.
In recent years, Professor Comi has received the ‘Gh. Marinescu’ honorary award from the Romanian Society of Neurology, and has been awarded honorary memberships of the Russian Neurological Academic Society, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), the European Neurological Society (ENS) and the Sociedad Espanola de Neurologia. He also received the Charcot Award for MS Research from the MS International Federation (MSIF) in 2015. Most recently, Professor Comi was awarded the Gold Medal of ‘Benemeranza Civica’ from the City of Milan. Prof. Comi has authored and co-authored more than 1000 articles in peer-reviewed journals, and edited several books, with an h-index of 100. He has been the invited speaker for more than 450 conferences, both nationally and internationally. He sits on the executive boards of various scientific associations and on the editorial boards of Clinical Investigation, European Journal of Neurology and Multiple Sclerosis. He is also the Associate Editor of the Neurological Sciences.
Media
